BRCA1 and ovarian carcinoma: Prior studies have elucidated key genes in the HR pathway, including, BRCA1, BRCA2, RAD51, and PALB2, that commonly have pathogenic germline variants and/or somatic mutations in breast and ovarian cancers (1).